Andi Wan
Chongqing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Research trends of neoadjuvant therapy for breast cancer: A bibliometric analysis.
Journal: Human vaccines & immunotherapeutics
Published: February 04, 2025
Application and prospect of organoid technology in breast cancer.
Journal: Frontiers in immunology
Published: April 08, 2024
Epigenetic regulation of diverse cell death modalities in cancer: a focus on pyroptosis, ferroptosis, cuproptosis, and disulfidptosis.
Journal: Journal of hematology & oncology
Published: December 19, 2023
Safety and efficacy of anlotinib combined with taxane and lobaplatin in neoadjuvant treatment of clinical stage II/III triple-negative breast cancer in China (the neoALTAL trial): a single-arm, phase 2 trial.
Journal: EClinicalMedicine
Published: December 15, 2023
Taxane combined with lobaplatin or anthracycline for neoadjuvant chemotherapy of triple-negative breast cancer: a randomized, controlled, phase II study.
Journal: BMC medicine
Published: October 17, 2023
Two Hematological Markers Predicting the Efficacy and Prognosis of Neoadjuvant Chemotherapy Using Lobaplatin Against Triple-Negative Breast Cancer.
Journal: The oncologist
Published: May 31, 2023
Conventional vs Minimally Invasive Breast Surgery-Reply.
Journal: JAMA surgery
Published: March 15, 2023
Artificial intelligence-assisted ultrasound image analysis to discriminate early breast cancer in Chinese population: a retrospective, multicentre, cohort study.
Journal: EClinicalMedicine
Published: February 07, 2023
An overview of the research progress of BRCA gene mutations in breast cancer.
Journal: Biochimica et biophysica acta. Reviews on cancer
Published: December 02, 2022
Molecular landscape and emerging therapeutic strategies in breast cancer brain metastasis.
Journal: Therapeutic advances in medical oncology
Published: July 23, 2022
A novel pyroptosis-related indicator of immune infiltration features and prognosis in breast cancer.
A novel pyroptosis-related indicator of immune infiltration features and prognosis in breast cancer.
Journal: Frontiers in oncology
Published: June 04, 2022
Showing 1-12 of 12
Last Updated: 09/26/2026